Pharmaceutical Supply – Guaifenesin Extended Release
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Contract for the Supply of Guaifenesin Extended Release tablets entails the provision of 25,000 boxes of pharmaceutical products meeting all applicable federal medical standards, ensuring safety, efficacy, and regulatory compliance. Each unit must be fully traceable through standardized military identification systems including the National Stock Number, Commercial and Government Entity code, and Transaction Control Number to maintain accountability and logistical integrity across the Defense Logistics Agency’s supply chain. This subcontract falls under the NAICS code 424210, which classifies pharmaceutical and cosmetic product merchant wholesalers, and is managed by the Department of Defense through the Defense Logistics Agency. The contract was posted on July 20, 2026, and its performance is governed by federal procurement protocols, with full traceability and compliance being mandatory for delivery acceptance. The award reference and delivery details are accessible via the official DIBBS portal using the provided contract and delivery identifiers.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
